# reload+after+2024-01-23 10:44:25.879845
address1§10260 Bubb Road
city§Cupertino
state§CA
zip§95014-4166
country§United States
phone§408 777 1417
fax§408 777 3577
website§https://www.durect.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
fullTimeEmployees§72
companyOfficers§[{'maxAge': 1, 'name': 'Dr. James E. Brown D.V.M.', 'age': 66, 'title': 'Co-Founder, CEO, President & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 885861, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Judy R. Joice', 'age': 66, 'title': 'Senior Vice President of Operations & Corporate Quality Assurance', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 451816, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Norman L. Sussman M.D.', 'age': 70, 'title': 'Chief Medical Officer', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 587945, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Timothy M. Papp M.B.A.', 'age': 47, 'title': 'CFO & Secretary', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jian  Li M.B.A.', 'age': 53, 'title': 'Interim Principal Accounting Officer, Senior VP of Finance, Corporate Controller & Secretary', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 297081, 'exercisedValue': 16406, 'unexercisedValue': 182381}, {'maxAge': 1, 'name': 'Dr. WeiQi  Lin M.D., Ph.D.', 'title': 'Executive VP of Research & Development and Principal Scientist', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Keith L. Lui M.B.A.', 'title': 'Senior Vice President of Business Development, Commercial & Medical Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Su Il Yum Ph.D.', 'age': 84, 'title': 'Executive Officer', 'yearBorn': 1939, 'fiscalYear': 2022, 'totalPay': 331744, 'exercisedValue': 62436, 'unexercisedValue': 162964}]
auditRisk§9
boardRisk§2
compensationRisk§5
shareHolderRightsRisk§7
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.874
priceToSalesTrailing12Months§1.8080971
currency§USD
dateShortInterest§1702598400
forwardEps§-1.05
pegRatio§-0.03
exchange§NCM
quoteType§EQUITY
shortName§DURECT Corporation
longName§DURECT Corporation
firstTradeDateEpochUtc§970147800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e77ce79d-8bdf-33c2-8d1b-fd9ac415ef17
gmtOffSetMilliseconds§-18000000
targetHighPrice§8.5
targetLowPrice§5.0
targetMeanPrice§6.75
targetMedianPrice§6.75
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§1.085
grossMargins§-2.83565
ebitdaMargins§0.0
trailingPegRatio§None
